News
Michael Keiser, PhD, and Kangway Chuang, PhD, want to use machine learning to speed the pace of drug discovery. By digging into the work of another lab, the pair realized how machine learning could lead scientists astray—and came up with methods to avoid its worst pitfalls.
Dong receives Daniel B. Smith Practice Excellence Award for exceptional career
Dong is a world expert on human immunodeficiency virus (HIV) and hepatitis C medication therapy
Making better pediatric chemo treatments, and delivering them to more children
Janel Long-Boyle has spent her career advancing chemotherapy treatments for young patients.
Kortemme and Desai honored at annual meeting of the American Institute for Medical and Biological Engineering
School of Pharmacy faculty members Tanja Kortemme and Tejal Desai both received honors at the annual meeting of the American Institute for Medical and Biological Engineering.
2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas
The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.
School of Pharmacy scientists unearth a new target for treating Parkinson’s disease
Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.
Desai named the director of new UCSF bioengineering initiative
The Health Innovation Via Engineering (HIVE) program is designed to inspire collaborations in bioengineering research.
School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year
Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.
USP/UCSF fellowship to support research in the quality and safety of medical products
A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients.
Medical and Pharmacy Students Jointly Tackle Health Care’s Most Pressing Dilemmas
A two-week course brought first-year UCSF medical and pharmacy students together, for the first time, to grapple with controversies and challenges in health care using scientific evidence and faculty-led discussion.
Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean
The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.
Creating an inexhaustible database for drug molecules
School of Pharmacy researchers helped a free public database of potential drug molecules grow 100-fold.
QBI fellowship fosters curiosity and perseverance for women scientists
Jacqueline Kyosiimire-Lugemwa, the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences, spent a year at UCSF in which her perseverance in the sciences was tested. She recently returned to her home country of Uganda more ready than ever to tackle big questions about HIV.
CRISPR-based obesity treatment shows promise for other diseases
A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.
Fraser appointed to Bowes Biomedical Investigator Program
Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.
Keiser receives $2.5 million to apply machine learning towards new therapies for Alzheimer’s, Parkinson’s
Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.
Combination drug therapy overcomes drug-resistant lung cancer in the lab
Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.
Ortiz de Montellano elected fellow of the Royal Society of Chemistry
Ortiz de Montellano gained renown for his work with cytochrome P450 enzymes, which help the liver metabolize drugs and other chemicals, and regulate hormone levels.